Biogen: Where Did That Come From?
July 02, 2015 at 15:30 PM EDT
Today, Biogen (BIIB) announced that it had partnered with Applied Genetic Technologies (AGTC) in a deal worth $1 billion. Maxim’s Jason Kolbert explains the logic behind the deal: This all started with CAR-T. What is CAR-T therapy? Simply put it’s the removal of a patients T-cells which are then engineered to express a receptor and injected [...]
